OTTAWA,
ON, May 17, 2024 /CNW/ - In Canada and across the world, microbes that
cause infections are becoming increasingly resistant to the drugs
designed to treat them - this is known as antimicrobial resistance
(AMR). While AMR can happen naturally, the misuse and overuse of
antimicrobials are accelerating its development and spread.
That is why today, the Honourable Mark Holland, Minister of
Heath, announced funding of up to $843,225 over three years to support the
development and dissemination of national antimicrobial prescribing
guidelines for 25 different syndromes in humans. These guidelines
would help optimize prescribing practices and reduce unnecessary or
inappropriate use of antimicrobials in Canada, which is one of the key drivers of
AMR.
The Association of Medical Microbiology and Infectious Disease
Canada (AMMI Canada) will develop the new guidelines and Firstline,
a Canadian technology platform, will disseminate the guidelines to
health care providers at the point-of-care through a digital
platform. Members of AMMI Canada and Firstline were instrumental in
the creation and distribution of the World Health Organization's
(WHO) AWaRe antibiotic book, an evidence-based antimicrobial
prescribing guidance document.
This investment is an important step forward in the work of the
Pan-Canadian Action Plan (PCAP) on Antimicrobial Resistance, which
was released in collaboration with provinces and territories on
June 2023. The federal government
will continue to build on this collaborative work with provincial
and territorial governments, Indigenous people, industry
stakeholders, and with partners across One Health sectors.
Continued collaboration will facilitate the implementation of the
Action Plan's 10 shared priorities and will help preserve the
effectiveness of these important drugs and to improve health
outcomes for everyone.
Quotes
"The development, dissemination, update, and promotion of
national prescribing guidelines for Canadian prescribers will be a
key tool in ensuring the appropriate and responsible use of
antibiotics for humans and contribute to the overall fight against
antimicrobial resistance. Working together, we will continue to
improve the health outcomes for all Canadians."
The Honourable Mark Holland
Minister of
Health
"The Association of Medical Microbiology and Infectious Disease
Canada is a national specialty society that represents Canadian
medical professionals working in infectious diseases and medical
microbiology. The development of evidence-based guidelines for the
empiric treatment of common syndromes for Canadian physicians will
optimize the treatment of infections and promote antimicrobial
stewardship, a key pillar in the PCAP fight against antimicrobial
resistance. AMMI Canada will apply a methodological framework to
adapt or adopt the WHO's AWaRe system and antibiotic book and will
develop a novel point-of-care educational guideline for
Canadians."
Dr. Deborah Yamamura, MD,
FRCPC
Past-President, AMMI Canada
Chair, AMMI
Canada AMR Guideline Steering Group
"Firstline is delighted to be deploying our service and
technology to manage and distribute national antimicrobial
prescribing guidance for the Government of Canada. Our experiences partnering with the
World Health Organization, other governments and healthcare
organizations give Firstline a unique ability to deliver clinical
guidance that produces real-world improvements in patient care.
Having deployed more sophisticated antimicrobial stewardship
interventions around the world than any other organization, we are
proud to play a national role in supporting healthcare providers at
home in Canada."
Dr Michael
Long
Chief Clinical Officer, Firstline
"Canada's adoption and
adaptation of guidelines based on the WHO's AWaRe system and
antibiotic book shows that AWaRe is a useful tool to improve
antibiotic prescribing worldwide. We are confident that this
project, which also provides digital access to guidance at the
point of care, will be a valuable support for prescribers."
Benedikt
Huttner
Unit Head Control and Response Strategies,
Division of Antimicrobial Resistance, WHO
Quick Facts
- The World Health Organization declared AMR a top ten public
health threat facing humanity. AMR is a leading cause of death
worldwide.
- AMR emerges naturally over time even when antimicrobials are
used appropriately. However, when antimicrobials are used
inappropriately in humans and animals, the emergence and spread of
AMR can be accelerated. This means that, in some cases,
antimicrobials lose their effectiveness faster.
- AMR is a serious threat to human and animal health. Essential
medical interventions such as organ transplantations, joint
replacements and chemotherapy are becoming riskier as the
antimicrobials used to prevent and treat infectious complications
from these interventions are losing their effectiveness.
- In Canada, AMR was estimated
to have caused 5,400 deaths, costing the healthcare system about
$1.4 billion, and reduced GDP by
$2 billion in 2018. These estimates
were published in the Council of Canadian Academies' Expert Panel
on the Potential Socio-Economic Impacts of Antimicrobial Resistance
in Canada.
Associated Links
Pan-Canadian Action Plan on Antimicrobial Resistance
AMMI Canada
Firstline
The WHO AWaRe antibiotic book
SOURCE Public Health Agency of Canada